Search by Drug Name or NDC

    NDC 71927-0019-02 MEDI-FIRST 1.3; 5 mg/g; mg/g Details

    MEDI-FIRST 1.3; 5 mg/g; mg/g

    MEDI-FIRST is a TOPICAL CREAM in the HUMAN OTC DRUG category. It is labeled and distributed by Orazen Inc. The primary component is BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE.

    Product Information

    NDC 71927-0019
    Product ID 71927-019_f5230137-32dd-0479-e053-2995a90a56f2
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name MEDI-FIRST
    Proprietary Name Suffix n/a
    Non-Proprietary Name Benzalkonium Chloride, Lidocaine
    Product Type HUMAN OTC DRUG
    Dosage Form CREAM
    Route TOPICAL
    Active Ingredient Strength 1.3; 5
    Active Ingredient Units mg/g; mg/g
    Substance Name BENZALKONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE
    Labeler Name Orazen Inc
    Pharmaceutical Class Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH NOT FINAL
    Application Number part348
    Listing Certified Through 2024-12-31

    Package

    NDC 71927-0019-02 (71927001902)

    NDC Package Code 71927-019-02
    Billing NDC 71927001902
    Package 25 POUCH in 1 BOX (71927-019-02) / .9 g in 1 POUCH (71927-019-01)
    Marketing Start Date 2023-02-20
    NDC Exclude Flag N
    Pricing Information N/A